Hsbc Holdings PLC Lowers Stake in Bath & Body Works, Inc. $BBWI

Hsbc Holdings PLC lessened its position in Bath & Body Works, Inc. (NYSE:BBWI) by 57.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 312,258 shares of the company’s stock after selling 426,002 shares during the period. Hsbc Holdings PLC’s holdings in Bath & Body Works were worth $6,333,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the company. AQR Capital Management LLC boosted its position in Bath & Body Works by 132.5% during the fourth quarter. AQR Capital Management LLC now owns 11,445,928 shares of the company’s stock worth $229,834,000 after acquiring an additional 6,523,960 shares during the last quarter. Alliancebernstein L.P. raised its holdings in Bath & Body Works by 2.2% in the 3rd quarter. Alliancebernstein L.P. now owns 5,861,444 shares of the company’s stock valued at $150,991,000 after acquiring an additional 123,648 shares during the last quarter. American Century Companies Inc. raised its holdings in Bath & Body Works by 2,204.1% in the 3rd quarter. American Century Companies Inc. now owns 5,174,370 shares of the company’s stock valued at $133,292,000 after acquiring an additional 4,949,796 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of Bath & Body Works by 2.9% during the 4th quarter. Geode Capital Management LLC now owns 3,960,475 shares of the company’s stock worth $79,542,000 after purchasing an additional 110,602 shares during the period. Finally, Bank of America Corp DE lifted its stake in shares of Bath & Body Works by 86.9% during the 3rd quarter. Bank of America Corp DE now owns 3,399,390 shares of the company’s stock worth $87,568,000 after purchasing an additional 1,580,176 shares during the period. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Stock Up 5.1%

BBWI stock opened at $22.93 on Friday. The company has a market cap of $4.62 billion, a price-to-earnings ratio of 6.44, a PEG ratio of 2.16 and a beta of 1.42. The business has a fifty day simple moving average of $19.14 and a 200-day simple moving average of $20.28. Bath & Body Works, Inc. has a 52 week low of $14.27 and a 52 week high of $33.96.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.03. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The business had revenue of $1.38 billion for the quarter, compared to analyst estimates of $1.36 billion. During the same period last year, the company posted $0.49 EPS. The business’s quarterly revenue was down 3.2% on a year-over-year basis. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. As a group, analysts expect that Bath & Body Works, Inc. will post 2.62 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, June 19th. Stockholders of record on Friday, June 5th were issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.5%. The ex-dividend date was Friday, June 5th. Bath & Body Works’s dividend payout ratio (DPR) is 22.47%.

Analysts Set New Price Targets

Several research firms have recently issued reports on BBWI. Barclays lowered their price objective on Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating for the company in a research report on Thursday, May 28th. TD Cowen increased their target price on Bath & Body Works from $20.00 to $25.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Weiss Ratings lowered Bath & Body Works from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Tuesday, June 2nd. UBS Group lowered their price target on Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating for the company in a report on Wednesday, May 20th. Finally, Wells Fargo & Company upped their price objective on shares of Bath & Body Works from $25.00 to $26.00 and gave the company an “overweight” rating in a research note on Tuesday. Three research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $22.00.

Bath & Body Works Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.